Showing results (741-750 of 1,042) with videos related to
Sort By:
Pageof 105
Current Opinion in Supportive and Palliative Care|March 12, 2025
Evaluation of the EORTC QLQ-C15-PAL and the FACIT-PAL-14 in assessing the quality of life in patients with advanced cancerPaula Tur, Eva Oldenburger, Andrew Bottomley, et al.Current Oncology (Toronto, Ont.)|August 25, 2023
A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast CancerRicardo Fernandes, Terry L Ng, Mashari Jemaan Alzahrani, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2011
Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancerDavid Cella, Sarah K Rosenbloom, Jennifer L Beaumont, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2008
Fatigue is the most important symptom for advanced cancer patients who have had chemotherapyZeeshan Butt, Sarah K Rosenbloom, Amy P Abernethy, et al.Seminars in Arthritis and Rheumatism|February 11, 2025
Psychometric properties of patient-reported outcomes measurement information system (PROMIS) fixed short forms in Juvenile MyositisKaveh Ardalan, Mariana C Marques, David Cella, et al.Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|May 3, 2019
Interviewer- versus self-administration of PROMIS® measures for adults with traumatic injuryPamela A Kisala, Aaron J Boulton, Matthew L Cohen, et al.Neuroimage. Clinical|April 6, 2017
Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concernsAlexandra C Apple, Anthony J Ryals, Kathryn I Alpert, et al.Clinical Orthopaedics and Related Research|June 11, 2021
Can the Knee Outcome and Osteoarthritis Score (KOOS) Function Subscale Be Linked to the PROMIS Physical Function to Crosswalk Equivalent Scores?Marilyn Heng, Xiaodan Tang, Benjamin D Schalet, et al.Journal of Pediatric Psychology|May 13, 2022
Measuring PROMIS® Emotional Distress in Early ChildhoodPhillip Sherlock, Courtney K Blackwell, Michael A Kallen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinomaBernard Escudier, Cezary Szczylik, Thomas E Hutson, et al.Pageof 105